<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04241666</url>
  </required_header>
  <id_info>
    <org_study_id>2020-01</org_study_id>
    <nct_id>NCT04241666</nct_id>
  </id_info>
  <brief_title>Sonographic Examination of Renal Function in Individuals With Long-term Spinal Cord Injury</brief_title>
  <official_title>Comparison of Sonographic Examination of Renal Function With Gold-standard Examination in Individuals With Long-term Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Paraplegic Centre Nottwil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lotte und Adolf Hotz-Sprenger Stiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swiss Paraplegic Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Paraplegic Centre Nottwil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with long-term lower urinary tract dysfunction due to spinal cord injury presenting
      for a routine urodynamic control will be screened for inclusion and exclusion criteria.
      Suitable individuals providing written informed consent will undergo renal Doppler sonography
      and renal scintigraphy in addition to the routine examinations. Conclusions regarding renal
      function based on the clearance rate determined by scintigraphy (gold standard) will be
      compared with the conclusions based on Doppler sonography and Cystatin C clearance.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>renal clearance</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>renal clearance of Technetium-99m-dimercaptosuccinic acid determined by scintigraphy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cystatin C concentration</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>blood serum concentration of Cystatin C (mg/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cystatin C clearance</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>renal clearance of Cystatin C (ml/min) according to the Grubb formula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal peak systolic velocity</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>Doppler sonography evaluation of renal blood flow during systolic heart phase (m/s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal peak enddiastolic velocity</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>Doppler sonography evaluation of renal blood flow during enddiastolic heart phase (m/s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal resistive index</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>(systolic velocity - enddiastolic velocity) / systolic velocity</description>
  </secondary_outcome>
  <other_outcome>
    <measure>size of kidneys</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>size of kidneys evaluated by sonography</description>
  </other_outcome>
  <other_outcome>
    <measure>renal tissue echogenicity</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>renal tissue echogenicity evaluated by sonography</description>
  </other_outcome>
  <other_outcome>
    <measure>bladder evacuation method</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>method of bladder evacuation</description>
  </other_outcome>
  <other_outcome>
    <measure>lesion level</measure>
    <time_frame>1 year after spinal cord injury</time_frame>
    <description>highest intact spinal cord segment</description>
  </other_outcome>
  <other_outcome>
    <measure>lesion severity</measure>
    <time_frame>1 year after spinal cord injury</time_frame>
    <description>severity of spinal cord injury according to American Spinal Injury Association Impairment Score (AIS) (A = motor and sensory complete, B = motor complete and sensory incomplete, C &amp; D = motor and sensory incomplete, E = motor and sensory intact)</description>
  </other_outcome>
  <other_outcome>
    <measure>duration of spinal cord injury</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>time from spinal cord injury to inclusion into study (years)</description>
  </other_outcome>
  <other_outcome>
    <measure>age</measure>
    <time_frame>at the time of inclusion into study</time_frame>
    <description>time from birth to inclusion into study (years)</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <condition>Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>normal renal function</arm_group_label>
    <description>individuals with renal clearance &gt;89 ml/min/1.73m²</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mild renal insufficiency</arm_group_label>
    <description>individuals with renal clearance 60-89 ml/min/1.73m²</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate renal insufficiency</arm_group_label>
    <description>individuals with renal clearance 30-59 ml/min/1.73m²</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>renal scintigraphy</intervention_name>
    <description>Technetium-99m-dimercaptosuccinic acid scintigraphy of both kidneys</description>
    <arm_group_label>mild renal insufficiency</arm_group_label>
    <arm_group_label>moderate renal insufficiency</arm_group_label>
    <arm_group_label>normal renal function</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>renal doppler sonography</intervention_name>
    <description>doppler ultrasound of both kidneys</description>
    <arm_group_label>mild renal insufficiency</arm_group_label>
    <arm_group_label>moderate renal insufficiency</arm_group_label>
    <arm_group_label>normal renal function</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        individuals with long-term lower urinary tract dysfunction due to spinal cord injury
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  long-term spinal cord injury (≥10 years)

          -  age ≥30 years

          -  written informed consent

        Exclusion Criteria:

          -  dementia or severe intellectual impairment

          -  serious internal illness

          -  previous or current tumor disease

          -  known allergy to the radioactive marker (Technetium)

          -  pregnancy or breastfeeding

          -  withdrawal of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Wöllner, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Swiss Paraplegic Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jens Wöllner, Dr.</last_name>
    <phone>+41 41 939 59 22</phone>
    <email>jens.woellner@paraplegie.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jürgen Pannek, Prof. Dr.</last_name>
    <phone>+41 41 939 59 22</phone>
    <email>juergen.pannek@paraplegie.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Swiss Paraplegic Centre</name>
      <address>
        <city>Nottwil</city>
        <state>LU</state>
        <zip>6207</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Jürgen Pannek, Prof. Dr.</last_name>
      <phone>+41 41 939 5922</phone>
      <email>juergen.pannek@paraplegie.ch</email>
    </contact>
    <contact_backup>
      <last_name>Jens Wöllner, Dr.</last_name>
      <phone>+41 41 939 5922</phone>
      <email>jens.woellner@paraplegie.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Jörg Krebs, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>data will be made available upon reasonable request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

